X4 Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.35-$6.96 |
Market Cap | $375.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $35.1M |
Revenue Growth (YoY) | 79.1% |
Gross Profit (12 Mos) | $29.3M |
Diluted EPS | -$1.87 |
News
See moreYahoo Finance • last month
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
Yahoo Finance • 5 months ago
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
Yahoo Finance • 5 months ago
Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates
About
CFO | Mr. David H. Kirske |
Address | 61 North Beacon Street, Boston, MA, United States, 02134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 45 |
